In Brief: Rhone-Poulenc Rorer Nasacort HFA
Executive Summary
Rhone-Poulenc Rorer Nasacort HFA: NDA is submitted Dec. 17 for a reformulated chlorofluorocarbon-free triamcinolone acetonide nasal inhaler using a tetrafluoroethane (HFA-134a) propellant...